Danaher Corporation $DHR Shares Sold by Eos Management L.P.

Eos Management L.P. lessened its stake in Danaher Corporation (NYSE:DHRFree Report) by 18.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 20,900 shares of the conglomerate’s stock after selling 4,634 shares during the quarter. Danaher accounts for about 1.6% of Eos Management L.P.’s portfolio, making the stock its 17th largest holding. Eos Management L.P.’s holdings in Danaher were worth $4,144,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in DHR. Sivia Capital Partners LLC boosted its holdings in shares of Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares during the last quarter. Janney Montgomery Scott LLC boosted its stake in Danaher by 7.7% during the second quarter. Janney Montgomery Scott LLC now owns 199,045 shares of the conglomerate’s stock worth $39,319,000 after buying an additional 14,277 shares during the period. Capital Investment Advisors LLC increased its position in shares of Danaher by 1.2% during the second quarter. Capital Investment Advisors LLC now owns 7,352 shares of the conglomerate’s stock valued at $1,452,000 after acquiring an additional 85 shares during the last quarter. Trivium Point Advisory LLC raised its stake in shares of Danaher by 35.4% in the 2nd quarter. Trivium Point Advisory LLC now owns 2,242 shares of the conglomerate’s stock valued at $443,000 after acquiring an additional 586 shares during the period. Finally, Liberty Capital Management Inc. lifted its holdings in shares of Danaher by 3.3% in the 2nd quarter. Liberty Capital Management Inc. now owns 35,300 shares of the conglomerate’s stock worth $6,973,000 after acquiring an additional 1,128 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Morgan Stanley initiated coverage on Danaher in a research report on Monday, December 1st. They issued an “overweight” rating and a $270.00 target price on the stock. TD Cowen restated a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Barclays boosted their price target on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn reaffirmed a “neutral” rating and set a $220.00 target price (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Twenty analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $252.70.

Get Our Latest Stock Report on Danaher

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Teri List sold 3,298 shares of Danaher stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 30,248 shares of company stock valued at $6,609,663. Company insiders own 11.20% of the company’s stock.

Danaher Trading Down 5.0%

NYSE DHR opened at $224.00 on Thursday. The firm’s fifty day moving average is $230.83 and its two-hundred day moving average is $213.77. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market cap of $158.22 billion, a PE ratio of 46.19, a P/E/G ratio of 3.59 and a beta of 0.89.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same quarter in the previous year, the company earned $2.14 EPS. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. Analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Key Danaher News

Here are the key news stories impacting Danaher this week:

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.